Pharmacological approaches to treating addiction are evolving rapidly, with growing evidence supporting the efficacy of medication-assisted interventions for diverse substances. Pharmacotherapy and medication-assisted treatment have transformed recovery trajectories for individuals struggling with opioids, alcohol, and even nicotine. Agents like buprenorphine, methadone, and naltrexone help mitigate withdrawal symptoms and reduce cravings while stabilizing long-term outcomes. Integration of behavioral support enhances the efficacy of these medications, providing a more comprehensive care pathway. Clinicians now focus on individualized treatment planning, ensuring the right pharmacological support is matched with the patient's physiological and psychological needs. As stigma diminishes, accessibility and adherence rates continue to improve.
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Gangstalking is real, should be studied
Sam Vaknin, Southern Federal University, United Kingdom
Title : Decoding aggression, violence, and substance use in adolescents with conduct disorders: Neurochemical pathways and interventions
Ann Marie Leonard Zabel, Curry College, United States
Title : Sensoria driven genetic decoupling and impaired areal integration in diseases of agency
Denis Larrivee, University of Navarra, Spain
Title : Positive outcome of adherence to the reward deficiency syndrome solution system treatment plan: A longitudinal study
Elizabeth Dale Gilley, The Elle Foundation, United States